Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events Academic Article Article uri icon

Overview

MeSH Major

  • Lipoproteins, HDL

abstract

  • Although homocysteine predicted future coronary events in AFCAPS/TexCAPS, we found little evidence that homocysteine evaluation provided an improved method to target statin therapy among those with low-to-normal LDL cholesterol levels.

publication date

  • April 16, 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000014447.06099.FB

PubMed ID

  • 11956118

Additional Document Info

start page

  • 1776

end page

  • 9

volume

  • 105

number

  • 15